Actipulse Neuroscience is a pioneering nanotechnology company that specializes in the research and engineering of Non-Invasive Brain Stimulation technologies. Their focus is on developing innovative solutions for the treatment of psychiatric and neurological disorders, such as Parkinson's, depression, anxiety, OCD, autism, and more. With a strong emphasis on respecting the highest clinical and ethical standards, Actipulse Neuroscience is dedicated to leading world-class research in this field.

Their current clinical pipeline includes studies on Major Depressive Disorder and drug delivery, with a vision to revolutionize neurodegenerative treatment. Backed by Y Combinator and with offices in Paris and Cambridge, MA, Actipulse Neuroscience aims to become the golden standard of neuromodulation technologies within the next five years. Their goal is to provide effective treatments for the millions of patients worldwide suffering from neurological and psychiatric disorders and dementia.

Visit their website to learn more about this revolutionary technology and join them in impacting the world of neuroscience. Actipulse Neuroscience: Rethinking Non-Invasive Brain Technologies